Expression and function of VEGF and its receptor KDR in pituitary tumors

Research output: Contribution to conference (unpublished) › Paper

Authors

Colleges, School and Institutes

Details

Original languageEnglish
PagesP2-231
Publication statusPublished - 1 Jan 2002
EventAnnual Meeting of the Endocrine Society, 84th -
Duration: 1 Jan 2002 → …

Conference

ConferenceAnnual Meeting of the Endocrine Society, 84th
Period1/01/02 → …
Save citation Saved citations (0)

Copy the text from this field...

View graph of relations

By the same authors

Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial

Neil Gittoes, Jan 2020, In : Osteoporosis International. 31, 1, p. 67-75 9 p.

Research output: Contribution to journal › Article

Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: a systematic review and network meta-analysis

Neil Gittoes, 3 Oct 2019, (Accepted/In press) In : Bone.

Research output: Contribution to journal › Article

Clinical, quality of life, and economic value of acromegaly disease control

Michael Sheppard, 1 Sep 2011, In : Pituitary. 14, 3, p. 284-294 11 p.

Research output: Contribution to journal › Article

Management of acromegaly in Latin America: expert panel recommendations

Michael Sheppard, 1 Jun 2010, In : Pituitary. 13, 2, p. 168-175 8 p.

Research output: Contribution to journal › Article